PROM1 and pancreatic neoplasm: In pancreatic cancer, highly metastatic cancer cells exhibit upregulation of Shh and CSC surface marker expression, including CD133 and CXCR4, associated with lower levels of let-7 expression as compared to parental BxPC-3 cells [92].